Add to a list

Inactive Instrument

CannaPharmaRX, Inc. Share Price Other OTC

CPMD

US13765D1090

Healthcare Facilities & Services

OTC Markets Traded

Valuation: CannaPharmaRX, Inc.

Market Cap	1.4M 1.25M 1.17M 1.06M 2M 134M 2.01M 14.05M 5.5M 69.12M 5.26M 5.15M 222M	P/E 2024	-0.51x	P/E 2025	-0.31x
Enterprise Value	22.05M 19.74M 18.4M 16.69M 31.48M 2.11B 31.68M 221M 86.56M 1.09B 82.83M 80.99M 3.5B	EV / Sales 2024	23,622,884x	EV / Sales 2025	17,663,843x
Free-Float	92.65%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: CannaPharmaRX, Inc.

08-18	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-20	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-31	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI
01-13	Cannapharmarx, Inc. Announces Resignation of Director Rick Orman, Effective January 8, 2026	CI
11-14	CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
19/08/25	Cannapharmarx, Inc. Plans to Open Its Sixth Growing Room in September	CI
19/08/25	Cannapharmarx, Inc. Announces Series of Strategic Developments	CI
19/08/25	Cannapharmarx, Inc. Announces Revenue Guidance for Third Quarter 2025	CI
14/08/25	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/05/25	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
10/04/25	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
09/04/25	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI

More news

Press Releases: CannaPharmaRX, Inc.

06/05/25	CannapharmaRx Continues into New European Market with First Shipment Completed to Germany	AQ
23/06/23	CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
22/12/22	Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	NE
21/12/22	CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	AQ
21/11/22	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ

More press releases

Managers and Directors: CannaPharmaRX, Inc.

Manager	Title	Age	Since
Constantine Nkafu CEO	Chief Executive Officer	50	06/09/2024
Oliver Foeste DFI	Director of Finance/CFO	50	12/10/2023

Director	Title	Age	Since
Dominick Colvin BRD	Director/Board Member	57	31/03/2018
Anthony Panek BRD	Director/Board Member	41	24/08/2023
Constantine Nkafu BRD	Director/Board Member	50	30/03/2025

More insiders

CannaPharmaRX Inc. is a Canada-based cannabis company focused on producing medical cannabis and craft products. The Company operates from its facility in Cremona, Alberta, Canada and is able to produce over 6,000 kilograms per year. The Company is focused on the acquisition, development, and operation of cannabis cultivation facilities in Canada. The Company produces and sells dried cannabis flower, which is packaged for sale as dried flower and trim shake. It sells dried flowers for medicinal purposes. The Company's products include unique genetics, craft products, medical cannabis, its brands and licenses. Craft cannabis, also known as craft marijuana, is cannabis that is produced on a small scale by artisanal or independent producers.

Employees

Sector

Healthcare Facilities & Services

More about the company

As early as today, start finding the best investment opportunities!

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNAPHARMARX, INC.	+0.08%	-.--%	-	-	1.4M
CVS HEALTH CORPORATION	+1.83%	+0.84%	+12.63%	+23.72%	112B
HCA HEALTHCARE, INC.	+1.66%	+5.44%	+10.47%	+95.17%	99.29B
NATERA, INC.	-0.73%	-6.55%	+134.99%	+909.82%	57.34B
FRESENIUS SE & CO. KGAA	+2.51%	-3.44%	-11.21%	+64.93%	27.05B
QUEST DIAGNOSTICS INCORPORATED	+0.72%	+0.18%	+26.38%	+92.86%	25.68B
LABCORP HOLDINGS INC.	+1.08%	+2.23%	+13.55%	+59.46%	25.59B
TENET HEALTHCARE CORPORATION	+1.89%	+3.58%	+41.77%	+408.63%	21.64B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.40%	-0.92%	-18.03%	-1.39%	21.01B
REDE D'OR SÃO LUIZ S.A.	+0.44%	+4.62%	+14.98%	+88.19%	20B
Average	+0.90%	+1.87%	+25.06%	+193.49%	45.53B
Weighted average by Cap.	+0.99%	+1.45%	+28.65%	+196.47%

	2024	2025
Net sales	0.82 0.73 0.68 0.62 1.17 78.4 1.18 8.22 3.22 40.46 3.08 3.01 130.19	1.36 1.22 1.14 1.03 1.94 130.21 1.96 13.66 5.35 67.2 5.12 5 216.23
Net income	-9.91M -8.87M -8.27M -7.5M -14.14M -947M -14.23M -99.34M -38.89M -489M -37.21M -36.39M -1.57B	-11.13M -9.96M -9.29M -8.43M -15.89M -1.06B -15.99M -112M -43.7M -549M -41.81M -40.89M -1.77B
Net Debt	14.06M 12.58M 11.73M 10.64M 20.07M 1.34B 20.2M 141M 55.19M 693M 52.81M 51.64M 2.23B	20.65M 18.48M 17.23M 15.63M 29.48M 1.97B 29.66M 207M 81.06M 1.02B 77.56M 75.85M 3.28B

CannaPharmaRX, Inc. Share Price Other OTC

Stocks

CPMD

US13765D1090

Healthcare Facilities & Services

Valuation: CannaPharmaRX, Inc.

Latest news: CannaPharmaRX, Inc.

Press Releases: CannaPharmaRX, Inc.

Quotes and Performance

Managers and Directors: CannaPharmaRX, Inc.

Medical Farming

Financials

Company Profile